A Pilot Study of FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

Trial Profile

A Pilot Study of FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 May 2017

At a glance

  • Drugs F-18 fluorothymidine (Primary)
  • Indications Solid tumours
  • Focus Diagnostic use
  • Most Recent Events

    • 08 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2018.
    • 08 May 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2018.
    • 08 May 2017 Status changed from suspended to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top